<?xml version="1.0" encoding="UTF-8"?>
<collection>
<dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:invenio="http://invenio-software.org/elements/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd"><dc:identifier>doi:10.1111/nmo.13180</dc:identifier><dc:language>eng</dc:language><dc:creator>Marsilio, I.</dc:creator><dc:creator>Caputi, V.</dc:creator><dc:creator>Cerantola, S.</dc:creator><dc:creator>Latorre Duque, E.</dc:creator><dc:creator>Paquola, A.</dc:creator><dc:creator>Pattarello, A.</dc:creator><dc:creator>Orso, G.</dc:creator><dc:creator>Mesonero, J.E.</dc:creator><dc:creator>Bertazzo, A.</dc:creator><dc:creator>Giron, M.C.</dc:creator><dc:title>Involvement of the serotonin pathway in ileal neruomotor dysfunction associated with TLR2 and TLR4 inhibition in juvenille mice</dc:title><dc:identifier>ART-2017-100636</dc:identifier><dc:description>Objective: Oxidized phospholipids (OxPAPC) inhibit TLR2-and TLR4-dependent signalling recognized to be involved in ensuring enteric nervous system (ENS) integrity. This study aimed to evaluate the effects of in vivo OxPAPC administration on ileal contractility and serotonin pathway in juvenile mice.</dc:description><dc:date>2017</dc:date><dc:source>http://zaguan.unizar.es/record/61931</dc:source><dc:doi>10.1111/nmo.13180</dc:doi><dc:identifier>http://zaguan.unizar.es/record/61931</dc:identifier><dc:identifier>oai:zaguan.unizar.es:61931</dc:identifier><dc:identifier.citation>NEUROGASTROENTEROLOGY AND MOTILITY 29, Suppl. 2 (2017), 14 [1 p.]</dc:identifier.citation><dc:rights>All rights reserved</dc:rights><dc:rights>http://www.europeana.eu/rights/rr-f/</dc:rights><dc:rights>info:eu-repo/semantics/openAccess</dc:rights></dc:dc>

</collection>